Many Older People Embrace Vaccines. Research Is Proving Them Right.
Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from…
Many Older People Embrace Vaccines. Research Is Proving Them Right.
Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out-of-pocket. Her doctor and several pharmacies turned her down because she was below the recommended…
Federal Proposals Threaten Provider Taxes, Key Source of Medicaid Funding for States
Republican efforts to restrict taxes on hospitals, health plans, and other providers that states use to help fund their Medicaid programs could strip them of tens of billions of dollars. The move could shrink access to health care for some of the nation’s poorest and most vulnerable people, warn analysts, patient advocates, and Democratic political…
Dr Kimmie Ng discusses young onset colorectal cancer
Dr Kimmie Ng discusses cancer with Dr. George Beauregard. Dr Ng heads the Young-Onset Colorectal Cancer Center, at the legendary Dana Farber Cancer Institute, and she treated George’s son who died age 32. Why are these cancers in younger people increasing so quickly? What can we do about it? What is connecting the environment, the…
New Cohere Health Solution Aims to Streamline Clinical Reviews for Payers
Cohere Health introduced a new tool for payers called Review Assist. It is meant to support health plan clinical staff with prior authorization reviews and other use cases. The post New Cohere Health Solution Aims to Streamline Clinical Reviews for Payers appeared first on MedCity News.
Precision Medicine Firm Caris Breaks Bio IPO Drought, Raising $494M for Cancer Analysis Tools
Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical-stage biotechs developing new drugs. The post Precision Medicine Firm Caris…
Why Intermountain Health Is Investing In AI for Clinical Data Abstraction
Intermountain Health is deploying Layer Health’s AI engine for clinical data abstraction across several of its patient registries. The health system’s venture capital arm is also making a strategic investment in the startup. The post Why Intermountain Health Is Investing In AI for Clinical Data Abstraction appeared first on MedCity News.
What OpenAI’s o3 Price Drop Means for the Future of AI in Healthcare?
To be clear, this doesn’t mean healthcare organizations should adopt LLMs tomorrow. But what’s changed is that the primary obstacle – cost at scale – is no longer the immovable obstacle it once was. For healthcare leaders who have been watching the AI wave from the sidelines, this is the moment to move from curiosity…
The MFN Executive Order: A Global Reset for U.S. Pharma
It’s a bold attempt to recalibrate global drug pricing — with U.S. patients at the center. But without clear enforcement, legal grounding, or international cooperation, its future remains very uncertain. The post The MFN Executive Order: A Global Reset for U.S. Pharma appeared first on MedCity News.
Weekend Reading
Impact of ‘One Big Beautiful Bill’ on rural hospital financesBrain implant lets patient with ALS speak and singImpact of children’s disability on parent’s mental health.COVID is back?How does this man defy aging?
An empirical test for the Fair Innings hypothesis
Suppose you have a single pill at your disposal and that pill will extend any person’s life by 10 years. You have to choose to give it to one of the following tow individuals: a 20‐year‐old patient, who will live for 10 more years if she gets the drug, and then she dies;a 70‐year‐old patient,…
